Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

FDA accepts amended BLA for Coagadex

May 28, 2015

Alnylam starts phase I trial of ALN-AS1 in patients with acute intermittent porphyria

May 27, 2015

U.S. fast track designations for luspatercept in beta-thalassemia

May 19, 2015

Bayer presents compounds for bleeding disorders

May 15, 2015

BioCryst starts phase I trial of second-generation oral kallikrein inhibitor for HAE

May 15, 2015

Sangamo Biosciences to target BCL11A for beta-thalassemia and SCD

May 15, 2015

Bayer dislcoses factor XIa and kallikrein B inhibitors

May 14, 2015

Sichuan Haisco Pharmaceutical discloses FXa inhibitors

May 6, 2015

Isis licenses ISIS-FXIRx to Bayer for prevention of thrombosis

May 5, 2015

Ixinity gains first approval for hemophilia B

May 4, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 27, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 27, 2025
Abbvie and Simcere enter a $1B T-cell engager deal
BioWorld Asia
Abbvie Inc. and Simcere Zaiming Pharmaceutical Co. Ltd. are part of the volley of large deals accompanying the opening of the 43rd annual J.P. Morgan Healthcare...
In monkeys, enhanced TB vaccine dissolves after inducing protection
BioWorld Science
An experimental tuberculosis (TB) vaccine with a dual mission – self-destruction after inducing immunity – improved the design of the Bacillus Calmette-Guérin...
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...